A
Sniderman 2003: ApoB and Non-HDL-C Superior to LDL-C
Sniderman AD, et al. • Lancet • 2003
ApoB and non-HDL-C provide superior cardiovascular risk prediction compared to LDL-C, particularly when triglycerides are elevated and LDL particles are small and dense.
Lipid MetabolismCardiovascularrisk assessment